14.40
+0.96
+(7.14%)
As of 3:29:02 PM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUWAERTER PAUL GISBERT Director | Purchase | Oct 6, 2023 | 5,000 |
| AVAT XAVIER Former | Sale | Apr 17, 2023 | 0 |
| BERGMANN ANTHONY Chief Financial Officer | Stock Award(Grant) | Jan 2, 2025 | 5,723 |
| COLLIER EARL M JR Director | Conversion of Exercise of derivative security | Apr 23, 2024 | 56,856 |
| KRASNEY KAREN General Counsel | Conversion of Exercise of derivative security | Dec 13, 2024 | 28,047 |
| LITVACK FRANK I Director | Conversion of Exercise of derivative security | Dec 3, 2024 | -- |
| MANZO LOUIS Director | Conversion of Exercise of derivative security | Feb 21, 2023 | 62,147 |
| MARBAN LINDA Chief Executive Officer | Conversion of Exercise of derivative security | May 12, 2023 | 198,604 |
| MUSKET DAVID B Director | Conversion of Exercise of derivative security | Aug 7, 2024 | 88,788 |
| NIPPON SHINYAKU CO., LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 20, 2024 | 7,090,350 |
Related Tickers
2LB.BE Iovance Biotherapeutics Inc
5.99
+0.67%
2LB.F Iovance Biotherapeutics, Inc.
5.99
+0.77%
MOOD.CN Doseology Sciences Inc.
0.1200
0.00%
IFRX InflaRx N.V.
2.4250
+2.32%
SLRX Salarius Pharmaceuticals, Inc.
2.2191
+3.23%
AUTL Autolus Therapeutics plc
2.1850
-0.68%
CABA Cabaletta Bio, Inc.
2.3250
-0.64%
CTXR Citius Pharmaceuticals, Inc.
2.6700
-5.65%
CRDF Cardiff Oncology, Inc.
4.0600
+2.27%
HOTH Hoth Therapeutics, Inc.
1.2550
-1.96%